Category Archives: Investor

A Look At The Role Guilherme Paulus Plays In The Growth Of CVC

Guilherme Paulus is the co-founder of CVC, a prominent travel agency and tour company. Guilherme Paulus has been part of the growth of CVC to become among the best travel and tour agencies in Latin America. As a retail tourism network, it has expanded to Brazil. His early career groomed him for the role he is playing in the company.

He was born in 1949 in Sao Paulo. Paulus graduated with a bachelor’s degree in Business Administration, a background that helped him to acquire relevant expertise in the tourism sector. With 50 years of experience in the industry, he has the best managerial skills. In 1972, he started the company with Vicente Cerchiari.

Since its conception, the company is always looking to occupy a leading position in Brazil. In line with that, Guilherme Paulus came up with strategies which made the company introduce new travel and tour packages. Furthermore, following those efforts to excel, CVC has earned worldwide recognition.

In 2009, the businessman went ahead to seek funding for his company in a global investment fund in an effort to expand to new markets. The funding helped it and in 2013, it started trading in stock exchange as a public company. Apparently, the expansion efforts has yielded fruits and now, they are hitting an annual profit of over $5 billion. It does not rest there, it is dedicated to explore markets and open 100 stores each year.

Guilherme Paulus has laid down an expansion strategy whereby he wants his company to expand to less populated areas throughout Latin America. Additionally, he is looking for ways to integrate online vendors with travel agencies by the use of Omni Channel Concept.

Through CVC, Guilherme Paulus cares about his community. In line with that, his company supports the PIET project based in Foz do Iguacu. PIET is a charity organization that looks to build a future for youngsters by training them to become the best tourism professionals. In addition to CVC’s charity endeavors, it funds the Alfasol-Solidarity Literacy.

Under the leadership of the successful career-man, CVC has outgrown its boundaries in the tourism industry.

Search more about Guilherme Paulus: https://www.istoedinheiro.com.br/guilherme-paulus-e-o-empreendedor-do-ano-2017-em-servicos/

What Paul Mampilly Had To Say on the Precision Industry’s Discovery

Paul Mampilly is the founder of the Capuchin consulting in Durma North Carolina. He has won several awards such as Templeton Foundation Investment Competition. Paul Mampilly is an MBA holder from Fordham University. He put to good use this education within the finance sector. He became an assistant portfolio manager for Bankers Trust in 1991. As he garnered more experience and expertise, he was admired by different legal firms such as ING and Deutsche Bank that hired him. Billion dollar corporations hired him after realizing that he had great potential. When holding the hedge funds manager position at Kinetics Asset management, its assets grew to $25 billions.

Wall Street later employed Paul Mampilly. During his service at Wall Street, he felt tired of making money for the rich. According to him, he was helping the rich to become richer. The common people had no one to help them improve their finance. He was determined to make a change, and that is why he started his newsletters. As of today, he had over 60,000 subscribers to his magazine. He feels motivated for helping such a larger number of people to improve their finances. The newsletters contain sound advice and investment tips that can be used by anyone to go ahead. He is populary featured on Bloomberg TV, CNBC and Fox Business.

Recently Paul Mampilly made a tease that triggered intense debate on the stock market. It was an advert on what he believed to be the biggest innovation in the medical history; what scientist believes could be a breakthrough in human medicine. The discovery was a mapping of the human DNA to find out which disease the person is at risk of getting. An appropriate treatment that the person could respond to would then be made based on their genetics. This type of medicine falls in the class of precision medicine industry.

Scientists believe that the precision industry is going to grow exponentially. If anyone buys stock in the industry, there are almost sure great returns. The company behind the discovery is Myriad Genetis (MYGN). Myriads stock has been growing in the recent, and it is expected that the trend will continue.

Paul Mampilly’s Facebook Page: www.facebook.com/PaulMampillyGuru/

Tagged